Comparer des méthodes
Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.
| Cancer Worry Scale× | FACT-Lung : Évaluation fonctionnelle des thérapies anticancéreuses× | |
|---|---|---|
| Domaine | Oncologie | Oncologie |
| Famille | Process / pipeline | Process / pipeline |
| Année d'origine≠ | 1991 | 1995 |
| Auteur d'origine≠ | Lerman, C., et al. | David F. Cella, Ph.D. |
| Type | Self-report questionnaire | Self-report questionnaire |
| Source fondatrice≠ | Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol, 10(1), 259–267. DOI ↗ | Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153. link ↗ |
| Alias | CWS | FACT-L |
| Apparentées | 5 | 5 |
| Résumé≠ | The Cancer Worry Scale (CWS) is a brief 8-item instrument assessing the degree to which cancer-related worry interferes with daily functioning and emotional well-being. Developed by Lerman et al. in 1991, it quantifies cancer-related anxiety and distress—psychological burden distinct from symptom burden and functional impairment. It is widely used in cancer screening, treatment, and survivorship contexts to identify patients requiring psychological support. | The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden. |
| ScholarGateJeu de données ↗ |
|
|